- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $21.37M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $17.91M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $40.39M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $131.93M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $497.92M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $513.03M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.84B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.29B |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $0 |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $0 |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $0 |
| Revenue | Q1 2025 · Mar 31, 2025 | $0 |
| Revenue | Q1 2025 · Mar 31, 2024 | $0 |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $329.23M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $428.6M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 71.9M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $9.52M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.66M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.16 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.16 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $6.41M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $11.24M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$11.42M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$38.78M |